Sensitivity to targeted UBA1 inhibition in a myeloid cell line model of VEXAS syndrome.
Publication information:
Adriana Chiaramida, Sandra G Obwar, Anja E H Nordstrom, Maria Ericsson, Aisha Saldanha, Elena Ivanova V, Gabriel K Griffin, Dilshad H Khan, and Roger Belizaire. 2023. “Sensitivity to Targeted UBA1 Inhibition in a Myeloid Cell Line Model of VEXAS Syndrome”. Blood Adv, 7, 24, Pp. 11